Mammoth Biosciences, Agilent to Comarket CRISPR-Based SARS-CoV-2 Test
The diagnostic is composed of Agilent's Bravo automation workstation and Mammoth's DETECTR BOOST SARS-CoV-2 assay.
In Brief This Week: OpGen, Hologic, Exact Sciences, Thermo Fisher, and More
News items for the in vitro diagnostics industry for the week of Jan. 4, 2021.
Mammoth Bio Signs Commercialization Deal for SARS CoV-2 Test With MilliporeSigma, Hamilton Company
The CRISPR-based test uses Mammoth's DETECTR BOOST platform and will be compatible with both nasal swab and saliva samples.
New Blood Test for Heart Attacks Developed With Potentially Greater Sensitivity
King's College London researchers reported that cardiac myosin-binding protein C might be more sensitive in detecting cell death due to a heart attack.